Travere Therapeutics, Inc.
HealthcareNASDAQ:TVTX · NASDAQ Global Market
+$3.11 today
Vol 2.38M · Avg 2.24M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+258.90%
Period High
$52.25
Period Low
$14.09
Latest
$52.04
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Legend Biotech Corporation
NASDAQ:LEGN
$6.64B
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.15B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.46B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.26B
Celcuity Inc.
NASDAQ:CELC
$4.31B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.11B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.66B
Disc Medicine, Inc.
NASDAQ:IRON
$2.60B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.40B
Ascentage Pharma Group International
NASDAQ:AAPG
$415.08M
What is the latest TVTX filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does TVTX have?
Intrinsic Alpha currently shows 20 recent filings for TVTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.